171 related articles for article (PubMed ID: 26074315)
1. Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes.
Vallejo-Vaz AJ; Kondapally Seshasai SR; Kurogi K; Michishita I; Nozue T; Sugiyama S; Tsimikas S; Yoshida H; Ray KK
Atherosclerosis; 2015 Aug; 241(2):409-18. PubMed ID: 26074315
[TBL] [Abstract][Full Text] [Related]
2. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
;
Lancet Diabetes Endocrinol; 2024 May; 12(5):306-319. PubMed ID: 38554713
[TBL] [Abstract][Full Text] [Related]
3. Statin diabetogenicity: guidance for clinicians.
Ray K
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S3. PubMed ID: 23819776
[TBL] [Abstract][Full Text] [Related]
4. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.
Braun LR; Feldpausch MN; Czerwonka N; Weiss J; Branch K; Lee H; Martinez-Salazar EL; Torriani M; Sponseller CA; Grinspoon SK; Stanley TL
J Clin Endocrinol Metab; 2018 Nov; 103(11):4176-4186. PubMed ID: 30239757
[TBL] [Abstract][Full Text] [Related]
5. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.
Macedo AF; Taylor FC; Casas JP; Adler A; Prieto-Merino D; Ebrahim S
BMC Med; 2014 Mar; 12():51. PubMed ID: 24655568
[TBL] [Abstract][Full Text] [Related]
6. Effect of steviol glycosides as natural sweeteners on glucose metabolism in adult participants.
Bai X; Qu H; Zhang J; Li L; Zhang C; Li S; Li G
Food Funct; 2024 Apr; 15(8):3908-3919. PubMed ID: 38512280
[TBL] [Abstract][Full Text] [Related]
7. The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis.
Dangas K; Navar AM; Kastelein JJP
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(6):622-632. PubMed ID: 35441656
[TBL] [Abstract][Full Text] [Related]
8. Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).
Nomura S; Taniura T; Shouzu A; Omoto S; Suzuki M; Okuda Y; Ito T
Vasc Health Risk Manag; 2018; 14():225-232. PubMed ID: 30271161
[TBL] [Abstract][Full Text] [Related]
9. Lower Glycosylated Hemoglobin Is Associated With Lower In-Hospital Mortality in Patients With COVID-19: A Systematic Review of the Literature and Meta-Analysis.
Tsikala Vafea M; Traboulsi C; Stefanovic-Racic M
Endocr Pract; 2024 Jan; 30(1):70-77. PubMed ID: 37769967
[TBL] [Abstract][Full Text] [Related]
10. Effect of pitavastatin on erythrocyte membrane fatty acid content in patients with chronic kidney disease: two-arm parallel randomized controlled trial.
Kim M; Kim SE; Lee SM; An WS
J Yeungnam Med Sci; 2024 May; ():. PubMed ID: 38715530
[TBL] [Abstract][Full Text] [Related]
11. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes.
Barrios V; Escobar C
Future Cardiol; 2016 Jul; 12(4):449-66. PubMed ID: 27076402
[TBL] [Abstract][Full Text] [Related]
13. A Trial of Pitavastatin Versus Rosuvastatin for Dyslipidemia in Chronic Kidney Disease.
Abe M; Maruyama N; Maruyama T; Okada K; Soma M
J Atheroscler Thromb; 2015; 22(12):1235-47. PubMed ID: 26156625
[TBL] [Abstract][Full Text] [Related]
14. Statin use and risk of new-onset diabetes: A meta-analysis of observational studies.
Casula M; Mozzanica F; Scotti L; Tragni E; Pirillo A; Corrao G; Catapano AL
Nutr Metab Cardiovasc Dis; 2017 May; 27(5):396-406. PubMed ID: 28416099
[TBL] [Abstract][Full Text] [Related]
15. Statin use and the risk of developing diabetes: a network meta-analysis.
Thakker D; Nair S; Pagada A; Jamdade V; Malik A
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1131-1149. PubMed ID: 27277934
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin: A Review in Hypercholesterolemia.
Hoy SM
Am J Cardiovasc Drugs; 2017 Apr; 17(2):157-168. PubMed ID: 28130659
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
Huang CH; Huang YY; Hsu BR
J Diabetes Investig; 2016 Sep; 7(5):769-76. PubMed ID: 27181110
[TBL] [Abstract][Full Text] [Related]
18. Pitavastatin therapy in polymedicated patients is associated with a low risk of drug-drug interactions: analysis of real-world and phase 3 clinical trial data.
Gosho M; Tanahashi M; Hounslow N; Teramoto T
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):635-46. PubMed ID: 26104032
[TBL] [Abstract][Full Text] [Related]
19. New onset diabetes mellitus induced by statins: current evidence.
Chrysant SG
Postgrad Med; 2017 May; 129(4):430-435. PubMed ID: 28276790
[TBL] [Abstract][Full Text] [Related]
20. Statins and risk for new-onset diabetes mellitus: A real-world cohort study using a clinical research database.
Yoon D; Sheen SS; Lee S; Choi YJ; Park RW; Lim HS
Medicine (Baltimore); 2016 Nov; 95(46):e5429. PubMed ID: 27861386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
